| ★ |  GLP-1 Discontinuation in Type 2 Diabetes: What Happens When Patients Stop? | | 64 | Estados Unidos | |
| 10 |  Are GLP1’s For Everyone? Which One Is Right For You? | Talking With Docs @talkingwithdocs | 191.9K | Canadá | 89 |
| 3 |  GLP-1s and Cardiovascular Risk: What the Latest Evidence Reveals | Metabolic Mind @metabolicmind | 49.3K | Estados Unidos | 90 |
| 18 |  GLP-1 Drugs: Dangers of Depression & Anxiety Revealed! | | 7.1K | Estados Unidos | 88 |
| 5 |  GLP-1 Medications: What You Need to Know | DarioHealth @dariohealthwellbeing | 711 | Estados Unidos | 89 |
| 9 |  When Your Diabetes Medication is the Latest Craze: Updates and Navigating Drug Shortages | Stanford Health Care @stanfordhospital | 600 | Estados Unidos | 89 |
| 4 |  GLP-1 Therapies: Where We’ve Been & Where We’re Going | Conversations on Health Care @cohcpodcast | 541 | Estados Unidos | 90 |
| 7 |  GLP-1 Medications for Weight Loss: the Latest Research | DarioHealth @dariohealthwellbeing | 365 | Estados Unidos | 89 |
| 2 |  GLP‑1s are everywhere — but what happens after you stop? | The KSL Noon Show @kslnoonshow | 341 | Estados Unidos | 91 |
| 17 |  Are #GLP-1s a lifetime prescription? | Rapid Response @rapidresponseshow | 341 | Estados Unidos | 88 |
| 20 |  Every company behind GLP1s documented what their drugs do... | | 302 | Reino Unido | 88 |
| 16 |  Berobenatide Monthly GLP-1 Injectable Shows Promise for Weight Loss | | 250 | Estados Unidos | 88 |
| 11 |  Rapid Evolution in GLP-1s and Therapeutics at ADA 2026 | | 171 | Estados Unidos | 89 |
| 14 |  GLP-1s: Miracle Weight Loss or Just Hype? #glp1 #weightlossstrategy #WeightLossDrugs | Live Long and Well With Dr. Bobby @drbobbylivelongandwell | 160 | Estados Unidos | 88 |
| 13 |  Why 80% of People Fail on GLP-1 Weight Loss Shots | Dr. Jeremy Landry, D.C. @drlandry | 119 | Estados Unidos | 89 |
| 15 |  GLP-1 Weight Loss Drugs : Miracle Cure or Costly Mistake? ( Facts vs Hype ) | Live Long and Well With Dr. Bobby @drbobbylivelongandwell | 113 | Estados Unidos | 88 |
| 1 |  Improving GLP-1 Adherence in Patients With Diabetes, With Vivian Fonseca, MD | | 91 | Estados Unidos | 92 |
| 8 |  From Lab to Patients | WebsEdgeMedicine @websedgemedicine | 82 | — | 89 |
| 12 |  Incretins, Monitors, and Insulin Titration at ADA 2026 | | 76 | Estados Unidos | 89 |
| 19 |  Diabetes Dialogue: Signos and the Science of Weight Loss | | 75 | Estados Unidos | 88 |
| 6 |  #62: GLP-1s: Life-Changing Results… at What Cost? | Live Long and Well With Dr. Bobby @drbobbylivelongandwell | 56 | Estados Unidos | 89 |